Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Nico GagelmannDirk-Jan EikemaLinda KosterTanja NetelenbosAndrew McDonaldAnne-Marie StoppaRoland FenkAchilles AnagnostopoulosGwendolyn N Y van GorkomErick DeconinckClaude-Eric BulaboisMichel DelforgeDonald BunjesWilliam ArcesePéter ReményiMaija Itälä-RemesLorenz ThurnerAli Zahit BolamanYafour NabilJohan LundHélène Labussière-WalletPatrick J HaydenMeral BeksacStefan SchönlandIbrahim Yakoub-AghaPublished in: European journal of haematology (2023)
Lenalidomide maintenance is standard of care for MM without EMD, whereas extramedullary organ involvement remains a significant risk factor for worse outcome, especially for early events after maintenance start.